Interventional Cardiology Devices And Equipment Market Size and Demand Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Interventional Cardiology Devices And Equipment Market show for the 2026–2030 period?
The interventional cardiology devices and equipment market has shown robust growth over recent years. It is projected to expand from $15.65 billion in 2025 to $16.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. The historical increase in this market can be attributed to factors such as the rising prevalence of cardiovascular diseases, the increased adoption of minimally invasive procedures, the expansion of cardiac catheterization laboratories, advancements in stent and catheter materials, and a growing aging population.
The market for interventional cardiology devices and equipment is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $21.76 billion, exhibiting a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period stems from factors such as a heightened demand for advanced interventional devices, the increasing integration of AI-assisted cardiac procedures, the broadening scope of outpatient and ambulatory cardiac care, a stronger emphasis on individualized patient therapies, and boosted investments in cardiovascular innovations. Key developments expected within the forecast timeframe encompass the wider acceptance of drug-eluting and bioabsorbable stents, an increased application of sophisticated catheter-based treatments, the expanding incorporation of imaging-guided interventional techniques, a broader implementation of minimally invasive cardiac procedures, and a heightened emphasis on both precision and patient safety.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2444&type=smp
What Drivers Are Shaping The Development Of The Interventional Cardiology Devices And Equipment Market?
The anticipated rise in cardiovascular diseases is projected to boost the expansion of the interventional cardiology devices and equipment market. These conditions encompass health issues linked to the heart, blood vessels, and the entire circulatory system. The growing prevalence of cardiovascular diseases is attributed to factors such as inadequate diets, sedentary lifestyles, stress, smoking, and obesity. The escalating occurrence of cardiovascular diseases is thereby stimulating the need for interventional cardiology devices, given that a greater number of heart patients seek sophisticated instruments for minimally invasive therapeutic procedures, consequently fostering market expansion. As an illustration, the Australian Institute of Health and Welfare, a government agency based in Australia, reported in October 2025 that cardiovascular disease represented nearly 12 percent of the total disease burden in Australia in 2024, specifically 14 percent for males and 10 percent for females. Furthermore, Australians collectively lost an estimated 685,000 years of healthy life, which translates to 25.5 per 1,000 population, attributable to various forms of cardiovascular disease. Consequently, the rising prevalence of cardiovascular diseases is anticipated to drive the future growth of the interventional cardiology devices and equipment market.
What Segment Types Are Examined In The Interventional Cardiology Devices And Equipment Market?
The interventional cardiology devices and equipment market covered in this report is segmented –
1) By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices
2) By Age Group: New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years)
3) By Application: Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers
Subsegments:
1) By Angioplasty Balloons: Normal Balloons, Drug-Eluting Balloons, Cutting Balloons
2) By Angioplasty Stents: Bare-Metal Stents (BMS), Drug-Eluting Stents (DES), Bioabsorbable Stents
3) By Catheters: Guiding Catheters, Balloon Catheters, Angiography Catheters
4) By Plaque Modification Devices: Atherectomy Devices, Thrombectomy Devices
5) By Other Interventional Cardiology Devices: Guidewires, Vascular Closure Devices, Inflation Devices
What Upcoming Trends Are Likely To Define The Future Path Of The Interventional Cardiology Devices And Equipment Market?
Companies operating within the interventional cardiology devices and equipment market are concentrating on advanced technological products, specifically percutaneous transluminal coronary angioplasty (PTCA), to satisfy the increasing need for minimally invasive procedures in treating cardiovascular diseases. The percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter, which incorporates Twin-Wall technology, delivers a superior solution for managing challenging coronary lesions. For example, in February 2023, SIS Medical AG, a medical company situated in Switzerland, introduced the OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter featuring Twin-Wall technology. This product is a next-generation balloon catheter designed to offer enhanced performance in complex coronary lesions. The OPN NC percutaneous transluminal coronary angioplasty (PTCA) catheter holds the potential to improve outcomes for patients suffering from coronary artery disease.
Who Are The Core Companies Influencing Trends In The Interventional Cardiology Devices And Equipment Market?
Major companies operating in the interventional cardiology devices and equipment market are GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Medtronic Inc., Johnson & Johnson, B. Braun Melsungen AG, Biosensors International Ltd, Cook Medical LLC, Biotronik SE & Co. KG, ACIST Medical Systems Inc., Cordis Corporation, Terumo Corporation, Cardinal Health Inc., iVascular GmbH, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, C. R. Bard Inc., Endologix Inc., Lombard Medical Limited, Spectranetics Corporation, Vascular Solutions Inc., W. L. Gore & Associates Inc., Cardiva Medical Inc., Cardiovascular Systems Inc., ClearStream Technologies Ltd., Contego Medical LLC, Shockwave Medical Inc.
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Interventional Cardiology Devices And Equipment Market?
North America was the largest region in the global interventional cardiology devices and equipment market in 2025. Western Europe was the second-largest region in the interventional cardiology devices and equipment market. The regions covered in the interventional cardiology devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Interventional Cardiology Devices And Equipment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2444&type=smp
Browse Through More Reports Similar to the Global Interventional Cardiology Devices And Equipment Market 2026, By The Business Research Company
Neuromodulation Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report
Internal Neuromodulation Devices Global Market Report 2026
Neurostimulation Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
